Background: There are often specific endoscopic findings caused by deposition of lanthanum (La) in the gastric mucosa of patients taking lanthanum carbonate (LaC), a novel phosphate binder for patients on hemodialysis. We conducted a retrospective study to investigate the clinical significance of La deposition in the gastric mucosa, and the association between endoscopic features and histologic findings in the same population.
Methods: We compared background factors in patients taking LaC with and without La deposition in their gastroscopic biopsy specimen. We also investigated the relationship between gastric endoscopic biopsy specimens with La deposition and the concurrent endoscopic images.
Results: There was a significant difference in the total dose of LaC between the La-positive and La-negative groups (990 g [180–3150 g] vs. 480 g [225–1328 g]; p=0.013). In 27 biopsy specimens with specific whitish mucosa, 10 showed mild histiocytic infiltration and 17 showed severe infiltration. In contrast, among 24 specimens with non-whitish mucosa, 5 showed no histiocytic infiltration, 10 showed mild infiltration, and 9 showed severe infiltration. There was a significant relationship between endoscopic features and the degree of histiocytic infiltration (p=0.026).
Conclusions: We demonstrated that La deposition in the gastric mucosa depended on the total dose of LaC and was not affected by background factors. The specific endoscopic features of La deposition are associated with the infiltration of histiocytes, which represents the body’s normal response to foreign bodies.
The protocol was registered in the University Hospital Medical Information Network Clinical Trial Registry (UMIN000038929).

Figure 1

Figure 1

Figure 2

Figure 2

Figure 3

Figure 3
Loading...
On 20 Nov, 2020
On 16 Nov, 2020
Posted 06 Nov, 2020
On 31 Oct, 2020
On 31 Oct, 2020
On 31 Oct, 2020
On 27 Oct, 2020
Received 12 Oct, 2020
On 23 Sep, 2020
Received 31 Aug, 2020
On 28 Jun, 2020
Invitations sent on 23 Jun, 2020
On 15 May, 2020
On 14 May, 2020
On 14 May, 2020
On 14 May, 2020
On 20 Nov, 2020
On 16 Nov, 2020
Posted 06 Nov, 2020
On 31 Oct, 2020
On 31 Oct, 2020
On 31 Oct, 2020
On 27 Oct, 2020
Received 12 Oct, 2020
On 23 Sep, 2020
Received 31 Aug, 2020
On 28 Jun, 2020
Invitations sent on 23 Jun, 2020
On 15 May, 2020
On 14 May, 2020
On 14 May, 2020
On 14 May, 2020
Background: There are often specific endoscopic findings caused by deposition of lanthanum (La) in the gastric mucosa of patients taking lanthanum carbonate (LaC), a novel phosphate binder for patients on hemodialysis. We conducted a retrospective study to investigate the clinical significance of La deposition in the gastric mucosa, and the association between endoscopic features and histologic findings in the same population.
Methods: We compared background factors in patients taking LaC with and without La deposition in their gastroscopic biopsy specimen. We also investigated the relationship between gastric endoscopic biopsy specimens with La deposition and the concurrent endoscopic images.
Results: There was a significant difference in the total dose of LaC between the La-positive and La-negative groups (990 g [180–3150 g] vs. 480 g [225–1328 g]; p=0.013). In 27 biopsy specimens with specific whitish mucosa, 10 showed mild histiocytic infiltration and 17 showed severe infiltration. In contrast, among 24 specimens with non-whitish mucosa, 5 showed no histiocytic infiltration, 10 showed mild infiltration, and 9 showed severe infiltration. There was a significant relationship between endoscopic features and the degree of histiocytic infiltration (p=0.026).
Conclusions: We demonstrated that La deposition in the gastric mucosa depended on the total dose of LaC and was not affected by background factors. The specific endoscopic features of La deposition are associated with the infiltration of histiocytes, which represents the body’s normal response to foreign bodies.
The protocol was registered in the University Hospital Medical Information Network Clinical Trial Registry (UMIN000038929).

Figure 1

Figure 1

Figure 2

Figure 2

Figure 3

Figure 3
Loading...